Evidence map›Paper›PMID 37955227›Full record

ArticleEMBO reports2023

RNF144A promotes antiviral responses by modulating STING ubiquitination.

Bo Yang, Jinyong Pei, Chen Lu, Yi Wang, Mengyang Shen, Xiao Qin, Yulu Huang, Xi Yang, Xin Zhao, Shujun Ma and 4 more

Open access · hybridAbstract read
In one paragraph

Article in EMBO reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Targeting ubiquitination in disease and therapy.Signal transduction and targeted therapy · 2025
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. The STING signaling pathways and bacterial infection.Apoptosis : an international journal on programmed cell death · 2025
    Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Bo Yang *Xinxiang Key Laboratory of Inflammation and Immunology, Xinxiang Medical University, Xinxiang, China.ORCID 0000-0002-0501-3201
Jinyong Pei *Xinxiang Key Laboratory of Inflammation and Immunology, Xinxiang Medical University, Xinxiang, China.
Chen Lu *Xinxiang Key Laboratory of Inflammation and Immunology, Xinxiang Medical University, Xinxiang, China.
Yi WangXinxiang Key Laboratory of Inflammation and Immunology, Xinxiang Medical University, Xinxiang, China.
Mengyang ShenXinxiang Key Laboratory of Inflammation and Immunology, Xinxiang Medical University, Xinxiang, China.
Xiao QinXinxiang Key Laboratory of Inflammation and Immunology, Xinxiang Medical University, Xinxiang, China.
Yulu HuangXinxiang Key Laboratory of Inflammation and Immunology, Xinxiang Medical University, Xinxiang, China.
Xi YangXinxiang Key Laboratory of Inflammation and Immunology, Xinxiang Medical University, Xinxiang, China.
Xin ZhaoDepartment of Laboratory Medicine, The Third Affiliated Hospital of Xinxiang Medical University, Xinxiang, China.
Shujun MaXinxiang Key Laboratory of Inflammation and Immunology, Xinxiang Medical University, Xinxiang, China.
Zhishan SongXinxiang Key Laboratory of Inflammation and Immunology, Xinxiang Medical University, Xinxiang, China.
Yinming LiangHenan Key Laboratory of Immunology and Targeted Drug, Xinxiang Medical University, Xinxiang, China.ORCID 0000-0001-9174-4037
Hui WangHenan Collaborative Innovation Center of Molecular Diagnosis and Laboratory Medicine, Xinxiang Medical University, Xinxiang, China.ORCID 0000-0002-2454-3814
Jie WangXinxiang Key Laboratory of Inflammation and Immunology, Xinxiang Medical University, Xinxiang, China.ORCID 0000-0003-4495-8862
Xinxiang Medical University · CNXinxiang University · CN

Funding

111 Plan | Overseas Expertise Introduction Project for Discipline Innovation D20036MOST | National Natural Science Foundation of China (NSFC) 31970847MOST | National Natural Science Foundation of China (NSFC) 32070949MOST | National Natural Science Foundation of China (NSFC) 32170871MOST | National Natural Science Foundation of China (NSFC) U2004103| Natural Science Foundation of Henan Province (Henan Natural Science Foundation) 212300410065| Natural Science Foundation of Henan Province (Henan Natural Science Foundation) 222300420064| Science and Technology Innovation Talents in Universities of Henan Province () 23HASTIT050
6 · The paper itself

Abstract

Stimulator of interferon (IFN) genes (STING, also named MITA, ERIS, MPYS, or TMEM173) plays an essential role in DNA virus- or cytosolic DNA-triggered innate immune responses. Here, we demonstrate that the RING-in-between RING (RBR) E3 ubiquitin ligase family member RING-finger protein (RNF) 144A interacts with STING and promotes its K6-linked ubiquitination at K236, thereby enhancing STING translocation from the ER to the Golgi and downstream signaling pathways. The K236R mutant of STING displays reduced activity in promoting innate immune signal transduction. Overexpression of RNF144A upregulates HSV-1- or cytosolic DNA-induced immune responses, while knockdown of RNF144A expression has the opposite effect. In addition, Rnf144a-deficient cells exhibit impaired DNA virus- or cytosolic DNA-triggered signaling, and RNF144A protects mice from DNA virus infection. In contrast, RNF144A does not affect RNA virus- or cytosolic RNA-triggered innate immune responses. Taken together, our findings identify a new positive regulator of DNA virus- or cytosolic DNA-triggered signaling pathways and a critical ubiquitination site important for fully functional STING during antiviral responses.

Indexed as

Herpesvirus 1, HumanAnimalsDNAImmunity, InnateMiceSTING ProteinUbiquitinationUbiquitin-Protein LigasesDNARnf144a protein, mouseSting1 protein, mouseSTING ProteinUbiquitin-Protein Ligasesantiviral innate immune responsesDNA virusposttranslational modificationsignal transductionubiquitination

Identifiers

PMID37955227
PMCPMC10702816
OpenAlexW4388632510

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.